Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Aydin Erenmemisoglu"'
Autor:
Ayşe Özlem Mete, Ayşe Vahapoğlu, Tuba Okatar Erözcan, Kübra Koçak, Figen Sarıgül, Arzu Nazlı Zeka, Devrim Demir Dora, Filiz Güldaval, Bengü Özütürk, Ceyda Anar, Osman Petek, Zafer Adıgüzel, Vildan Avkan-Oğuz, Ata Nevzat Yalçın, Gülru Polat, Muzaffer Onur Turan, Ömer Demir, İlkay Karaoğlan, Derya Seyman, Yeşim Tunçok, Oğuz Kılınç, Ali Necati Gökmen, Dilara İnan, Ülkü Aygen Türkmen, Bünyamin Sertoğullarından, Şükran Köse, Aydın Erenmemişoğlu
Publikováno v:
İstanbul Medical Journal, Vol 25, Iss 1, Pp 49-55 (2024)
Introduction: Coronavirus diseases-2019 (COVID-19) have been ongoing for more than two years. Despite the scientific research conducted in this process, there is still no widely accepted definitive treatment for the disease. For treating COVID-19, us
Externí odkaz:
https://doaj.org/article/9147b9d0e9f24e03bb718bf6181f7c03
©2022 Dustri-Verlag Dr. K. Feistle.Objective: To investigate the recovery of monoamine oxidase (MAO) activity in the liver and gut of healthy subjects after a dose of 10 mg of the irreversible MAO inhibitor tranylcypromine (TCP). Materials and metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c5b820e603631c0c5095d25f8e0613a
https://avesis.kayseri.edu.tr/publication/details/bcba9f00-c3f1-4e62-bb33-2f0dd570495f/oai
https://avesis.kayseri.edu.tr/publication/details/bcba9f00-c3f1-4e62-bb33-2f0dd570495f/oai
Autor:
Aydin Erenmemisoglu, Mike John van der Meer, Recep Serdar Alpan, Rossen Koytchev, Yildiz Ozalp
Publikováno v:
Arzneimittelforschung. 54:573-577
The study was designed to evaluate the relative bioavailability of two formulations of atorvastatin (CAS 134523-03-8). A bioequivalence study was carried out in 24 healthy male volunteers who received four 10 mg tablets of the test formulation (Koles
Autor:
Recep Serdar Alpan, Mike John van der Meer, Rossen Koytchev, Yildiz Ozalp, Aydin Erenmemisoglu
Publikováno v:
Arzneimittelforschung. 54:624-628
The study was designed to evaluate the bioavailability of two rofecoxib (CAS 162011-90-7) tablet formulations. Twenty-four healthy male volunteers were administered a 25 mg tablet of the test formulation (Ecrox) containing rofecoxib or the originator
Publikováno v:
Arzneimittelforschung. 53:289-293
Objective: The present study was conducted with the aim of investigating which acceptance criteria for bioequivalence are relevant for orally applied antimycotics using terbinafine (CAS 78628-80-5) as an example. Methods: A bioequivalence trial was p
Autor:
Rossen Koytchev, Recep Serdar Alpan, Mike John van der Meer, Yildiz Ozalp, Aydin Erenmemisoglu
Publikováno v:
Arzneimittelforschung. 54:605-610
The aim of the present studies, performed in two different groups of volunteers, was to compare the bioavailability of 20 mg lisinopril tablets (Sinopryl as test and an orignator product as reference formulation; study 1) and lisinopril/hydrochloroth
Publikováno v:
Arzneimittelforschung. 54:634-639
Sultamicillin (CAS 76497-13-7) is a pro-drug of a combination of ampicillin and sulbactam linked as a double ester. The aim of the present studies, performed in two different groups of volunteers, was to compare the bioavailability of 750 mg sultamic
Autor:
Reinhard Sailer, Peter Arnold, Aydin Erenmemisoglu, A. Atilla Hincal, Uygur Tamur, Ilker Kanzik, Wolfgang Martin
Publikováno v:
Arzneimittelforschung. 57:232-237
Sultamicillin (CAS 76497-13-7) is a prodrug combination of ampicillin (CAS 69-53-4) and sulbactam (CAS 68373-14-8), with the antibiotic ampicillin and the beta-lactamase inhibitor sulbactam chemically linked as double ester. The present study was per
Autor:
Ilker Kanzik, A. Atilla Hincal, Peter Arnold, Aydin Erenmemisoglu, Uygur Tamur, Wolfgang Martin, Reinhard Sailer
Publikováno v:
Arzneimittelforschung. 57:227-231
The aim of the present study was to compare the bioavailability of amoxicillin (CAS 26787-78-0) from two different amoxicillin tablets (Demoksil 1 g tablet as test preparation and 1 g tablet of the originator product as reference preparation). The st
Autor:
Peter Arnold, Reinhard Sailer, Aydin Erenmemisoglu, Ilker Kanzik, Uygur Tamur, A. Atilla Hincal, Wolfgang Martin
Publikováno v:
Arzneimittelforschung. 57:462-466
Two different tablets containing amlodipine besylate (CAS 111470-99-6) (Vazkor 10 mg tablet as test preparation and 10 mg tablet of the originator product as reference preparation) were investigated in 18 healthy male volunteers in order to compare t